Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 fold » _ fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 fold » _ fold (Expand Search)
-
1261
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. …”
-
1262
SPL decreases diabetes-induced oxidative stress in GL and PT.
Published 2017“…Similar results were found between CTL and SPL groups. Data are mean±SEM from 5–6 rats per group. *p<0.05; **p<0.01 and ***p<0.001.…”
-
1263
-
1264
-
1265
-
1266
PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues.
Published 2013“…One unit means a decrease in OD<sub>620</sub> per second. …”
-
1267
-
1268
The expression of genes related to mitochondria was decreased in Pgam2 mice.
Published 2013“…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
-
1269
-
1270
-
1271
-
1272
-
1273
-
1274
-
1275
Acute JMV2959 treatment decreases alcohol preference in rats.
Published 2013“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”
-
1276
-
1277
Acute JMV2959 treatment decreases alcohol intake in rats.
Published 2013“…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …”
-
1278
-
1279
-
1280